Literature DB >> 10488178

Epidemiological evidence for dormant Cryptococcus neoformans infection.

D Garcia-Hermoso1, G Janbon, F Dromer.   

Abstract

To date, the time of acquisition of a Cryptococcus neoformans infectious strain has never been studied. We selected a primer, (GACA)(4), and a probe, CNRE-1, that by randomly amplified polymorphic DNA (RAPD) analysis and restriction fragment length polymorphism (RFLP), respectively, regrouped strains from control samples of C. neoformans var. grubii environmental isolates according to their geographical origins. The two typing techniques were then used to analyze 103 isolates from 29 patients diagnosed with cryptococcosis in France. Nine of the 29 patients lived in Africa a median of 110 months prior to moving to France; 17 of the patients originated from Europe. Results showed a statistically significant clustering of isolate subtypes from patients originating from Africa compared to those from Europe. We conclude that the patients had acquired the C. neoformans infectious strain long before their clinical diagnoses were made.

Entities:  

Mesh:

Year:  1999        PMID: 10488178      PMCID: PMC85528          DOI: 10.1128/JCM.37.10.3204-3209.1999

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure.

Authors:  S P Franzot; J S Hamdan; B P Currie; A Casadevall
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Rapid method to extract DNA from Cryptococcus neoformans.

Authors:  A Varma; K J Kwon-Chung
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

3.  Isolation of Cryptococcus neoformans from soil.

Authors:  C W EMMONS
Journal:  J Bacteriol       Date:  1951-12       Impact factor: 3.490

4.  The commensalism of Cryptococcus neoformans.

Authors:  D H Howard
Journal:  Sabouraudia       Date:  1973-07

5.  Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.

Authors:  S P Franzot; I F Salkin; A Casadevall
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group.

Authors:  F Dromer; S Mathoulin; B Dupont; A Laporte
Journal:  Clin Infect Dis       Date:  1996-07       Impact factor: 9.079

7.  Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group.

Authors:  M E Brandt; L C Hutwagner; L A Klug; W S Baughman; D Rimland; E A Graviss; R J Hamill; C Thomas; P G Pappas; A L Reingold; R W Pinner
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  Random amplified polymorphic DNA analysis of clinically and environmentally isolated Cryptococcus neoformans in Nagasaki.

Authors:  Y Yamamoto; S Kohno; H Koga; H Kakeya; K Tomono; M Kaku; T Yamazaki; M Arisawa; K Hara
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City.

Authors:  B P Currie; L F Freundlich; A Casadevall
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

10.  Diversity of DNA fingerprints in Cryptococcus neoformans.

Authors:  A Varma; D Swinne; F Staib; J E Bennett; K J Kwon-Chung
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

View more
  123 in total

1.  Cryptococcal Meningitis in HIV-Infected Patients.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

Review 2.  Role of phagocytosis in the virulence of Cryptococcus neoformans.

Authors:  Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2004-10

3.  Susceptibility to Cryptococcal Meningoencephalitis Associated With Idiopathic CD4+ Lymphopenia and Secondary Germline or Acquired Defects.

Authors:  Anil A Panackal; Lindsey B Rosen; Gulbu Uzel; Michael J Davis; Guowu Hu; Adebowale Adeyemo; Fasil Tekola-Ayele; Andrea Lisco; Christopher Diachok; Jonathan D Kim; Dawn Shaw; Irini Sereti; Jennifer Stoddard; Julie Niemela; Sergio D Rosenzweig; John E Bennett; Peter R Williamson
Journal:  Open Forum Infect Dis       Date:  2017-06-07       Impact factor: 3.835

4.  Rat eosinophils stimulate the expansion of Cryptococcus neoformans-specific CD4(+) and CD8(+) T cells with a T-helper 1 profile.

Authors:  Ana P Garro; Laura S Chiapello; José L Baronetti; Diana T Masih
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

5.  Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection.

Authors:  Kirsten Nielsen; Gary M Cox; Anastasia P Litvintseva; Eleftherios Mylonakis; Stephanie D Malliaris; Daniel K Benjamin; Steven S Giles; Thomas G Mitchell; Arturo Casadevall; John R Perfect; Joseph Heitman
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study.

Authors:  Madeleine Okome-Nkoumou; Vincent Guiyedi; Magloire Ondounda; Nora Efire; Philippe Clevenbergh; Mireille Dibo; Arnaud Dzeing-Ella
Journal:  Am J Trop Med Hyg       Date:  2013-12-09       Impact factor: 2.345

7.  Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.

Authors:  Robert W Maitta; Kausik Datta; Andrew Lees; Shelley Sims Belouski; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Diagnosis and successful treatment of Cryptococcus neoformans variety grubii in a domestic ferret.

Authors:  Christopher S Hanley; Peter MacWilliams; Steve Giles; Jean Paré
Journal:  Can Vet J       Date:  2006-10       Impact factor: 1.008

9.  Titan cells in Cryptococcus neoformans: cells with a giant impact.

Authors:  Oscar Zaragoza; Kirsten Nielsen
Journal:  Curr Opin Microbiol       Date:  2013-04-12       Impact factor: 7.934

10.  Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease?

Authors:  Joseph N Jarvis; Thomas S Harrison; Elizabeth L Corbett; Robin Wood; Stephen D Lawn
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.